-
The Belmont Report has withstood the test of time as a framework for ethical decision making about human subjects research, experts in research ethics say.
-
The FDA announced in early November that it was strengthening its safety program for marketed drugs. Lester M. Crawford, DVM, PhD, acting FDA commissioner, says that he has authorized the Center for Drug Evaluation and Research (CDER) to take the following measures.
-
IRB processes are so varied from hospital to hospital that they can unnecessarily impede multicenter trials, according to a survey that looked at the responses of 68 hospitals to one study.
-
Disappointed by a funding gap in the federal support of stem cell research, the citizens of California have made the decision to directly involve the State in the research effort.
-
The St. Louis-based genomic medicine development company GenoMed is taking a novel approach to testing its hypothesis that inflammation-reducing heart medications can be effective in treating severe complications of influenza.
-
The Centers for Medicare & Medicaid Services (CMS) has issued the first in a projected series of seven papers to provide guidance for covered entities.
-
An elderly man diagnosed with rheumatoid arthritis was prescribed methotrexate by his doctor. Although he immediately began to experience symptoms of methotrexate toxicity, the doctor failed to take the patients complaints seriously and refilled the prescription for another month. The man continued to experience the same symptoms and, two weeks later, he was rushed to an emergency department for treatment. The ED physicians were unable to prevent the mans death, which they attributed to methotrexate toxicity.
-
Thomson American Health Consultants has developed an influenza sourcebook to ensure you and your hospital are prepared for what could happen this flu season or the next.
-
After hosting the recent National Summit on Medical Abbreviations with several other organizations, JCAHO modified the 2005 requirements for meeting National Patient Safety Goal 2b Standardize the abbreviations, acronyms and symbols used throughout the organization, including a list of abbreviations, acronyms and symbols not to use.
-
Taking the idea of full disclosure to another level, a Seattle hospital has posted a public apology to the victim of a medical error with apparently no regard to how that may affect the inevitable lawsuit from the family.